PS

Padakanti Sunitha

Active Director Director DIN 09403249
DIN 09403249 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Padakanti Sunitha

Data last updated:

Padakanti Sunitha is a Director at Medikasurgi Healthcare Private Limited (since 2021). The company operates in Healthcare. Medikasurgi Healthcare Private Limited reported revenue of ₹19.78 Cr (FY 2025).

DIN 09403249
Primary Designation Director
Industry Healthcare
First Appointment 17 Nov 2021
Oldest Company Age 4 yrs
Largest company Medikasurgi Healthcare Private Limited · ₹19.78 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20212021₹19.78 Cr (FY 2025)Active

Board colleagues of Padakanti Sunitha

Directorship timeline

Open interactive timeline →
Medikasurgi Healthcare Private Limited
Premium access

Shareholding and investment profile for Padakanti Sunitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padakanti Sunitha

Padakanti Sunitha currently holds 1 directorship: Medikasurgi Healthcare Private Limited (Director, since 17 Nov 2021, revenue ₹19.78 Cr (FY 2025)).

Padakanti Sunitha was first appointed on 17 Nov 2021 as Director at Medikasurgi Healthcare Private Limited.

The current boards of Padakanti Sunitha's companies include Madhu Sudarshan Padakanti (Medikasurgi Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available